Zhengye Biotechnology Holding Ltd Cash Flow Statement

Cash Flow Statement Dec2022 Dec2023 Dec2024
Operating Activities
Net Income 8.11M5.31M1.85M
Depreciation and Depletion 2.33M2.86M2.84M
Deferred Taxes -0.20M0.08M0.13M
Gains from Investment Securities 1.26M1.48M-0.02M
Asset Writedowns and Impairment 1.45M1.42M0.82M
Change in Working Capital 0.21M
Change in Receivables 3.72M-4.39M-2.24M
Change in Inventory 1.84M1.83M0.81M
Change in Account Payables -1.44M-5.04M-0.06M
Change in Accured Expenses 0.03M-0.08M0.37M
Change in Taxes 0.48M-1.09M-0.03M
Other Working Capital Changes 0.05M-0.10M-0.06M
Cash from Operations 2.58M6.82M5.62M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 2.80M3.38M3.31M
Investing Activities
Capital Expenditures 4.07M1.05M1.86M
Sales of Property, Plant and Equipment 0.15M0.02M
Change in Intangibles 0.59M1.94M
Cash from Investing Activities -4.07M-1.66M-3.79M
Financing Activities
Other financing activities 0.64M0.48M
Cash from Financing Activities 2.00M-2.69M-3.08M
Dividend Payments
Dividends Paid - Common 3.19M5.58M2.19M
Additional items
Exchange Rate Effect 0.02M
Change in Cash 0.52M2.47M-1.20M
Beginning Cash Balance 0.94M-0.33M3.75M
Free Cash Flow -1.49M5.77M3.76M
Net Cash Flow 0.52M2.47M-1.25M